Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-01-03

Clinical Trial Update: Subacromial Methylprednisolone Versus Ketorolac for Shoulder Impingement [Phase 2]

View source ↗

Summary

Phase 2 trial comparing subacromial methylprednisolone to ketorolac for shoulder impingement was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLPREDNISOLONE (methylprednisolone)
  • Toradol (ketorolac tromethamine)

Snippet

Sponsor: The University of Texas Medical Branch, Galveston | Conditions: Subacromial Impingement, Subacromial Impingement Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2025-01-03